Analysts expect Aclaris Therapeutics, Inc. to report revenue of 1.34 M for Q3 26, against a range of 1.30 M to 1.39 M. The most recent reported quarter, Q2 26, came in at 1.63 M, a 22.1% beat against the 1.33 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 4.35 M | 9.21 M | 1.46 M | 1.78 M | 3.30 M | 1.29 M | 2.00 M | 1.63 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 1.68 M | 2.10 M | 3.26 M | 1.57 M | 1.56 M | 2.12 M | 1.30 M | 1.42 M | 1.39 M | 1.47 M | 1.59 M | 1.54 M | 1.54 M | 1.42 M | 1.66 M | 1.76 M | ||||||||||
| Low Estimate | 1.56 M | 1.85 M | 2.95 M | 1.34 M | 1.37 M | 1.90 M | 1.16 M | 1.25 M | 1.30 M | 1.33 M | 1.32 M | 1.34 M | 1.34 M | 1.29 M | 1.47 M | 1.49 M | ||||||||||
| Consensus Estimate | 1.62 M | 1.98 M | 3.11 M | 1.46 M | 1.46 M | 2.01 M | 1.23 M | 1.33 M | 1.34 M | 1.40 M | 1.45 M | 1.44 M | 1.44 M | 1.36 M | 1.56 M | 1.62 M |
Analysts expect Aclaris Therapeutics, Inc. to report earnings per share of -0.15 for Q3 26, against a range of -0.16 to -0.14. The most recent reported quarter, Q2 26, came in at -0.15 , in line with the -0.15 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.11 | -1.01 | -0.12 | -0.13 | -0.12 | -0.16 | -0.15 | -0.15 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.01 | -0.25 | -0.15 | -0.11 | -0.13 | -0.13 | -0.15 | -0.15 | -0.14 | -0.15 | -0.17 | -0.16 | -0.18 | -0.20 | -0.12 | -0.16 | ||||||||||
| Low Estimate | -0.01 | -0.29 | -0.17 | -0.13 | -0.15 | -0.15 | -0.17 | -0.15 | -0.16 | -0.17 | -0.21 | -0.18 | -0.20 | -0.22 | -0.12 | -0.18 | ||||||||||
| Consensus Estimate | -0.01 | -0.27 | -0.16 | -0.12 | -0.14 | -0.14 | -0.16 | -0.15 | -0.15 | -0.16 | -0.19 | -0.17 | -0.19 | -0.21 | -0.12 | -0.17 |
Pull Wall Street consensus for Aclaris Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ACRS&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ACRS", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ACRS&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();